Part 3 of 6—The Path From Thalidomide, to Revlimid, to a 340B Whistleblower Lawsuit
The myeloma drugs Revlimid and Pomalyst are analogues of Thalomid, aka thalidomide—a drug that still haunts those who remember the late 1950s and early 1960s. Marketed mainly in Europe as an over the counter sedative and morning sickness medicine for pregnant women, thalidomide deformed their babies’ limbs or caused stillbirth. “Thalidomide changed our relationship with new medicines forever,” the U.K.’s national Science Museum says. “It resulted in tighter drug testing and reporting of side-effects.” In the U.S., Congress responded to the thalidomide tragedy in 1962 with legislation requiring drugs for the first time to be proven safe and effective before they could be approved and marketed.
The myeloma drugs Revlimid and Pomalyst are analogues of Thalomid, aka thalidomide—a drug that still haunts those who remember the late 1950s and early 1960s. Marketed mainly in Europe as an over the counter sedative and morning sickness medicine for pregnant women, thalidomide deformed their babies’ limbs or caused stillbirth. “Thalidomide changed our relationship with new medicines forever,” the U.K.’s national Science Museum says.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
